secwatch / observer
8-K filed December 15, 2025, 6:59 PM ET ticker WLK CIK 0001262823
other material confidence high sentiment negative materiality 0.90

Westlake approves closure of three chlorovinyl plants and styrene unit, expects $415M in pre-tax costs

WESTLAKE CORP

item 2.05item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-25-318445
form_type
8-K
ticker
WLK
cik
0001262823
company_name
WESTLAKE CORP
filed_at
2025-12-15T23:59:59+00:00
discovered_at
2026-05-14T18:02:39.000262+00:00
generated_at
2026-05-16T13:11:02.246531+00:00
sec_items
["2.05", "7.01", "9.01"]
event_type
other_material
sentiment
negative
materiality_score
0.9
calibrated_materiality_score
0.9
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-25-318445
json_url
https://secwatch.observer/filing/0001193125-25-318445.json
markdown_url
https://secwatch.observer/filing/0001193125-25-318445.md
text_url
https://secwatch.observer/filing/0001193125-25-318445.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1262823/000119312525318445/0001193125-25-318445-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1262823/000119312525318445/d798286d8k.htm
generated_by_model
deepseek-v4-flash:cloud
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

3cb91552c6ac76afa62058e633453816765cea5c

WESTLAKE CORP announced a restructuring with charges of approximately $415 million affecting North American chlorovinyl production facilities and styrene production plant (approximately 295 employees).

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

SEC 8-K Item 2.05/2.06 confidence 0.9 SEC evidence

Comparable filings

KOP

Koppers conditionally plans to shut Stickney, IL chemical operations; Q1 adjusted EPS down 19.7%

Koppers Holdings Inc. May 8, 2026, 7:59 PM ET other_material Items 2.02, 2.05, 5.02, 5.07, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

potentially appropriate uses for the Stickney facility following the end of production activities. The Company expects this action to result in pre-tax charges to earnings of $227 million to $262 million through the end of 2029, approximately $170 million to $195 million of which constitutes non-cash charges and approximately $57 million to $67 million of which

Filing page SEC filing

NET

Cloudflare Q1 revenue $639.8M +34% YoY; announces 20% workforce reduction

Cloudflare, Inc. May 7, 2026, 7:59 PM ET other_material Items 2.02, 2.05, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

On May 7, 2026, the Company announced a plan (the “Plan”) designed to further accelerate its evolution to an agentic AI-first operating model. As part of the Plan, the Company expects to reduce its current workforce by approximately 20%. The Company currently estimates that it will incur charges of between $140 million and $150 million in connection with the Plan

Filing page SEC filing

SNAP

Snap reports Q1 rev ~$1.53B (+12% YoY), adj EBITDA ~$233M; cuts 16% of staff (~1,000 jobs)

Snap Inc April 15, 2026, 7:59 PM ET other_material Items 2.02, 2.05, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

increased operational efficiencies to accelerate our path toward net-income profitability. As a result, we currently estimate that we will incur pre-tax charges in the range of $95 million to $130 million, primarily consisting of severance and related costs, contract termination costs, and other impairment charges, of which $75 million to $100 million are expected

Filing page SEC filing

CRMT

America's Car-Mart to close 42 stores (31% of total); non-cash impairment ~$14M due to capital constraints

AMERICAS CARMART INC April 7, 2026, 7:59 PM ET other_material Items 2.05, 2.06, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

the Company expects to record a non-cash impairment charge of approximately $14 million related to assets at the closing locations.

Filing page SEC filing

TEAM

Atlassian to cut ~10% workforce (~1,600 roles); CTO Rajeev Rajan departing

Atlassian Corp March 11, 2026, 7:59 PM ET other_material Items 2.05, 7.01, 5.02, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

efficiency and sustainability. Position eliminations in each country are subject to local law and consultation requirements. The Company estimates it will incur approximately $225 million to $236 million in charges in connection with these actions, of which approximately $169 million to $174 million is expected to result in future cash outlays related to

Filing page SEC filing

INM

InMed to wind down BayMedica commercial ops; focus shifts to Alzheimer's, AMD pipeline

InMed Pharmaceuticals Inc. March 6, 2026, 6:59 PM ET other_material Items 2.05, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

In connection with the wind down of commercial operations, BayMedica is expected to incur severance and other employee-related costs of approximately $550,000 and expects to incur additional related expenditures of approximately $120,000 through the end of the fiscal year.

Filing page SEC filing

TBPH

Theravance Biopharma Phase 3 CYPRESS study fails; plans 50% workforce cut and strategic review

Theravance Biopharma, Inc. March 3, 2026, 6:59 PM ET other_material Items 2.02, 2.05, 7.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

On March 3, 2026, the Company announced an organizational restructuring (the “Restructuring”), which is intended to reduce cost base by approximately 60% (or approximately $70 million) and expected to impact approximately 50% of the Company’s overall workforce. The Restructuring will be implemented over the next two quarters, with the Company expecting to incur approximately $5 million to $7 million in one-time cash severance costs related to the Restructuring.

Filing page SEC filing

BCAB

BioAtla initiates strategic review, cuts 70% workforce; CFO replaced; cash ~$7.1M

BioAtla, Inc. March 2, 2026, 6:59 PM ET other_material Items 2.02, 7.01, 2.05, 5.02, 8.01, 9.01

same fact type: restructuring_charge same SEC item: 2.05, 7.01, 9.01 same event type: other_material similar materiality

This filing

The closures of the facilities are expected to result in a workforce reduction of approximately 295 employees. The Company expects it will incur total pre-tax costs of approximately $415 million related to the closures of the facilities consisting of noncash accelerated depreciation, amortization, and asset write-off charges of approximately $357 million, employee severance and separation costs of approximately $25 million, and other plant shut down costs of approximately $33 million.

Comparable filing

formal process to explore and evaluate strategic options to maximize shareholder value. The total cash payments related to this workforce reduction are estimated to be between $0.5 and $0.6 million related to employee severance and benefit costs. The Company expects to pay for the majority of these costs in the first quarter of 2026. The estimates of the

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-25-318445
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.